Beyond blood sugar: Why managing diabetes means caring for your eyes too
Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic ...
EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...
Opthea to Host Investor Days in New York and Australia
Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on ...
WebMD1d
New Therapy Brings Hope for Dry AMD Vision Loss
The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
Association of Optometrists1d
My CPD New Year resolution
The beginning of the new CPD cycle means it is time to prepare a new professional development plan (PDP) and sketch out areas ...
ONL Therapeutics Appoints Penny Fleck as Chief Development Officer
In September, ONL announced the closing of a $65 million Series D financing round, led by Johnson & Johnson Innovation – JJDC, Inc. The Series D funding supports the advancement of the development of ...
Soliddd introduces smart glasses to enable vision for people with macular degeneration
SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.
These unique smart glasses skirt hype and solve a real medical problem
SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects millions but has no medical cure.